These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37705133)

  • 1. Cyclodextrin based nanoparticles for smart drug delivery in colorectal cancer.
    Marabada D; Li J; Wei S; Huang Q; Wang Z
    Chem Biol Drug Des; 2023 Dec; 102(6):1618-1631. PubMed ID: 37705133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
    Lakkakula JR; Maçedo Krause RW
    Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Advances of Lipid Nanoparticles in the Treatment of Colorectal Cancer.
    Zhang J; Ali K; Wang J
    Int J Nanomedicine; 2024; 19():6693-6715. PubMed ID: 38979534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional co-transport carriers based on cyclodextrin assembly for cancer synergistic therapy.
    Yi S; Liao R; Zhao W; Huang Y; He Y
    Theranostics; 2022; 12(6):2560-2579. PubMed ID: 35401819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer.
    Wang K; Shen R; Meng T; Hu F; Yuan H
    Molecules; 2022 May; 27(9):. PubMed ID: 35566331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in the Pharmaceutical and Biomedical Applications of Cyclodextrin-Capped Gold Nanoparticles.
    Abdellatif AAH; Ahmed F; Mohammed AM; Alsharidah M; Al-Subaiyel A; Samman WA; Alhaddad AA; Al-Mijalli SH; Amin MA; Barakat H; Osman SK
    Int J Nanomedicine; 2023; 18():3247-3281. PubMed ID: 37337575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model.
    Ünal S; Can Öztürk S; Bilgiç E; Yanık H; Korkusuz P; Aktaş Y; Benito JM; Esendağlı G; Bilensoy E
    Eur J Pharm Biopharm; 2021 Dec; 169():168-177. PubMed ID: 34700001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
    Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
    Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiphilic cyclodextrin nanoparticles.
    Varan G; Varan C; Erdoğar N; Hıncal AA; Bilensoy E
    Int J Pharm; 2017 Oct; 531(2):457-469. PubMed ID: 28596142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Cyclodextrins in Nanoparticle-Based Drug Delivery Systems.
    Shelley H; Babu RJ
    J Pharm Sci; 2018 Jul; 107(7):1741-1753. PubMed ID: 29625157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles for Colorectal Cancer Targeted Drug Delivery and MR Imaging: Current Situation and Perspectives.
    Dong Z; Cui MY; Peng Z; Li Y; Wang X; Fang Z; Jiang M; Xu L; Luo Y; Li ZP; Feng ST
    Curr Cancer Drug Targets; 2016; 16(6):536-50. PubMed ID: 26632434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal Cancer Management by Herbal Drug-Based Nanocarriers: An Overview.
    Kulwal V; Baxi K; Sawarkar SP; Bhatt LK
    Crit Rev Ther Drug Carrier Syst; 2020; 37(1):65-104. PubMed ID: 32450014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted nanoparticles for colorectal cancer.
    Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
    Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailoring renal-clearable zwitterionic cyclodextrin for colorectal cancer-selective drug delivery.
    Baek MJ; Nguyen DT; Kim D; Yoo SY; Lee SM; Lee JY; Kim DD
    Nat Nanotechnol; 2023 Aug; 18(8):945-956. PubMed ID: 37106052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered nanoparticles for imaging and drug delivery in colorectal cancer.
    Pavitra E; Dariya B; Srivani G; Kang SM; Alam A; Sudhir PR; Kamal MA; Raju GSR; Han YK; Lakkakula BVKS; Nagaraju GP; Huh YS
    Semin Cancer Biol; 2021 Feb; 69():293-306. PubMed ID: 31260733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.
    Salústio PJ; Pontes P; Conduto C; Sanches I; Carvalho C; Arrais J; Marques HM
    AAPS PharmSciTech; 2011 Dec; 12(4):1276-92. PubMed ID: 21948320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer management: strategies in drug delivery.
    Singh P; Waghambare P; Khan TA; Omri A
    Expert Opin Drug Deliv; 2022 Jun; 19(6):653-670. PubMed ID: 35656670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micelles as potential drug delivery systems for colorectal cancer treatment.
    Fatfat Z; Fatfat M; Gali-Muhtasib H
    World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Advances in Chitosan-based Drug Delivery Systems for Colorectal Cancer: A Narrative Review.
    Ali DS; Othman HO; Anwer ET
    Curr Pharm Biotechnol; 2023; 24(12):1554-1559. PubMed ID: 36733239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrins-modified metallic nanoparticles for effective cancer therapy.
    Gandhi S; Shende P
    J Control Release; 2021 Nov; 339():41-50. PubMed ID: 34560156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.